Integrated clinicopathological and treatment outcome analysis of extra cranial malignant germ cell tumors in children and adolescents in India – A retrospective multicentre study- INPHOG GCT -22-01 (CoI)
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2024 - 65535
Project Lead
Dr. Shubha AM
Authors
Dr. Shubha AM
Project Status
ongoing